- Revenue rose to $80.67M for Q3 2026 from $71.91M in the prior year period.
- Net income attributable to company reached $4.64M vs $3.51M; diluted EPS rose to $0.11 from $0.09.
- Operating cash flow for nine months increased to $35.46M compared to $33.48M.
Signal #135223 · SEC 8-K
$VMD SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $VMD filing catalyst
Why did $VMD trigger an AI stock catalyst alert?
$VMD triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.0/10). Headline: Viemed Healthcare Reports Q3 2026: Revenue Up 12% to $80.7M, Diluted EPS $0.11. Key points: - Revenue rose to $80.67M for Q3 2026 from $71.91M in the prior year period. - Net income attributable to company reached $4.64M vs $3.51M; diluted EPS rose to $0.11 from $0.09. - Operating cash flow for nine months increased to $35.46M compared to $33.48M.
How did $VMD stock react after the SEC filing?
After the SEC 8-K for $VMD, observed market reaction: T0 price $10.11. Past moves do not guarantee future results.
Where can I get real-time $VMD SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $VMD via Telegram and the VIP Web Terminal from €10/month.